Rapid, low-cost fluorescent assay of β-lactamase-derived antibiotic resistance and related antibiotic susceptibility

Abstract. Antibiotic resistance (AR) is increasingly prevalent in low and middle income countries (LMICs), but the extent of the problem is poorly understood. This lack of knowledge is a critical deficiency, leaving local health authorities essentially blind to AR outbreaks and crippling their ability to provide effective treatment guidelines. The crux of the problem is the lack of microbiology laboratory capacity available in LMICs. To address this unmet need, we demonstrate a rapid and simple test of β-lactamase resistance (the most common form of AR) that uses a modified β-lactam structure decorated with two fluorophores quenched due to their close proximity. When the β-lactam core is cleaved by β-lactamase, the fluorophores dequench, allowing assay speeds of 20 min to be obtained with a simple, streamlined protocol. Furthermore, by testing in competition with antibiotics, the β-lactamase-associated antibiotic susceptibility can also be extracted. This assay can be easily implemented into standard lab work flows to provide near real-time information of β-lactamase resistance, both for epidemiological purposes as well as individualized patient care.

[1]  Derek F. J. Brown,et al.  Evaluation of the E test, a novel method of quantifying antimicrobial activity. , 1991, The Journal of antimicrobial chemotherapy.

[2]  Giulio Jori,et al.  Photodynamic therapy in the treatment of microbial infections: Basic principles and perspective applications , 2006, Lasers in surgery and medicine.

[3]  M. Kostrzewa,et al.  Matrix-Assisted Laser Desorption Ionization–Time of Flight Mass Spectrometry-Based Functional Assay for Rapid Detection of Resistance against β-Lactam Antibiotics , 2011, Journal of Clinical Microbiology.

[4]  M. Aidoo Divining without seeds: The case for strengthening laboratory medicine in Africa , 2011 .

[5]  V. Gill,et al.  Correlation of penicillin minimum inhibitory concentrations and penicillin zone edge appearance with staphylococcal beta-lactamase production , 1981, Journal of clinical microbiology.

[6]  M. Ferraro Performance standards for antimicrobial susceptibility testing , 2001 .

[7]  N. Woodford Rapid characterization of beta-lactamases by multiplex PCR. , 2010, Methods in molecular biology.

[8]  J. Sherris,et al.  Antibiotic sensitivity testing. Report of an international collaborative study. , 1971, Acta pathologica et microbiologica Scandinavica. Section B: Microbiology and immunology.

[9]  G. Jacoby,et al.  Mechanisms of disease: The new β-lactamases , 2005 .

[10]  I. Okeke Divining without Seeds: The Case for Strengthening Laboratory Medicine in Africa , 2011 .

[11]  Clsi Performance Standards for Antimicrobial Susceptibility Testing: Twenty-First Informational Supplement , 2010 .

[12]  REPORT OF AN INTERNATIONAL COLLABORATIVE STUDY TO EVALUATE A WHO HIV-1 RNA GENOTYPE REFERENCE PANEL , 2003 .

[13]  D. Livermore beta-Lactamases in laboratory and clinical resistance , 1995, Clinical microbiology reviews.

[14]  J. Lakowicz Principles of fluorescence spectroscopy , 1983 .

[15]  Andreas Wieser,et al.  MALDI-TOF MS in microbiological diagnostics—identification of microorganisms and beyond (mini review) , 2011, Applied Microbiology and Biotechnology.

[16]  Victor L. Yu,et al.  Outcome of Cephalosporin Treatment for Serious Infections Due to Apparently Susceptible Organisms Producing Extended-Spectrum β-Lactamases: Implications for the Clinical Microbiology Laboratory , 2001, Journal of Clinical Microbiology.

[17]  R. Cantón,et al.  Variations in the prevalence of strains expressing an extended-spectrum beta-lactamase phenotype and characterization of isolates from Europe, the Americas, and the Western Pacific region. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[18]  A. Bauer,et al.  Antibiotic susceptibility testing by a standardized single disk method. , 1966, American journal of clinical pathology.

[19]  H. Goossens,et al.  Antibiotic resistance—the need for global solutions , 2013, BDJ.

[20]  Clinical,et al.  Performance standards for antimicrobial disk susceptibility tests : approved standard , 2006 .

[21]  V. Lorian Antibiotics in laboratory medicine , 2005 .

[22]  G. Papanicolaou,et al.  Discrimination of extended-spectrum beta-lactamases by a novel nitrocefin competition assay , 1990, Antimicrobial Agents and Chemotherapy.

[23]  A. L. Koch Penicillin Binding Proteins, β-Lactams, and Lactamases: Offensives, Attacks, and Defensive Countermeasures , 2000, Critical reviews in microbiology.

[24]  Suzanne Fery-Forgues,et al.  ARE FLUORESCENCE QUANTUM YIELDS SO TRICKY TO MEASURE? A DEMONSTRATION USING FAMILIAR STATIONERY PRODUCTS , 1999 .

[25]  Ulysses W. Sallum,et al.  Rapid Functional Definition of Extended Spectrum β‐Lactamase Activity in Bacterial Cultures via Competitive Inhibition of Fluorescent Substrate Cleavage , 2010, Photochemistry and photobiology.

[26]  D. Livermore,et al.  Detection of beta-lactamase-mediated resistance. , 2001, The Journal of antimicrobial chemotherapy.

[27]  K. Thomson,et al.  Detection of extended-spectrum beta-lactamases in members of the family Enterobacteriaceae: comparison of the double-disk and three-dimensional tests , 1992, Antimicrobial Agents and Chemotherapy.

[28]  Ulysses W. Sallum,et al.  Exploiting a bacterial drug-resistance mechanism: a light-activated construct for the destruction of MRSA. , 2009, Angewandte Chemie.

[29]  T. Hasan,et al.  Functional Targeting of Bacteria: A Multimodal Construct for PDT and Diagnostics of Drug-Resistant Bacteria , 2014 .

[30]  T. F. Smith,et al.  Real-Time PCR in Clinical Microbiology: Applications for Routine Laboratory Testing , 2006, Clinical Microbiology Reviews.

[31]  P. Nordmann,et al.  Emerging carbapenemases in Gram-negative aerobes. , 2002, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[32]  G Sherman,et al.  The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. , 2000, Chest.

[33]  G. Jacoby,et al.  The new beta-lactamases. , 2005, The New England journal of medicine.

[34]  Ulysses W. Sallum,et al.  Rapid optical determination of β-lactamase and antibiotic activity , 2014, BMC Microbiology.

[35]  G. Jacoby,et al.  A functional classification scheme for beta-lactamases and its correlation with molecular structure , 1995, Antimicrobial agents and chemotherapy.

[36]  D. Livermore,et al.  Detection of β-lactamase-mediated resistance , 2001 .

[37]  J. Rodríguez-Baño,et al.  Clinical significance of extended-spectrum β-lactamases , 2008, Expert review of anti-infective therapy.